Come up with a name for your new list and we'll add to it:
Carmell Therapeutics raised a round of funding on May 19, 2014. Investors include
National Institutes of Health.
Carmell Therapeutics is developing biologically-active medical devices manufactured from blood plasma with growth and regenerative factors designed by nature in the right proportions to heal tissues. …